Yew Bio-Pharm Group, Inc. announced earnings results for the second quarter ended June 30, 2019. For the second quarter, the company announced total revenue was USD 12.565 million compared to USD 14.820 million a year ago. Operating income was USD 1.136 million compared to USD 2.066 million a year ago. Net income was USD 1.436 million compared to USD 1.613 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago. For the half year, total revenue was USD 24.079 million compared to USD 17.851 million a year ago. Operating income was USD 1.681 million compared to USD 2.285 million a year ago. Net income was USD 1.813 million compared to USD 1.762 million a year ago. Basic earnings per share from continuing operations was USD 0.03 compared to USD 0.03 a year ago.